Mayne Pharma is an Australia-based specialty pharmaceutical company that offers services such as contract development and manufacturing for the life science sector.
Business Model:
Revenue: $301.8M
Employees: 501-1,000
Address: 1538 Main North Road
City: Salisbury
State: south australia
Zip: 5106
Country: AU
Mayne Pharma is an Australia-based specialty pharmaceutical company that offers services such as contract development and manufacturing for the life science sector.
Contact Phone:
Contact Email:
Listed Exchange:
Australian Securities Exchange
IPO Date:
7/6/2007
Ticker Symbol:
MYX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2018 | Hedgepath Pharmaceuticals | Post-IPO Equity | - |
7/2018 | Hedgepath Pharmaceuticals | Post-IPO Equity | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2012 | Post-IPO Equity | $2.7M | 6/2015 | Debt | $125M | 1/2013 | Equity | $141.8k |
---|
Announced Date | Name | Price |
---|---|---|
10/2012 | Metrics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|